Registry for Abbott's heart devices
Abbott Structural Heart Device Registry
This study is collecting information to see how safe and effective Abbott's heart devices are for patients getting them implanted in real-life hospital settings.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2500 (estimated) |
| Sex | All |
| Sponsor | Abbott Medical Devices Industry-sponsored |
| Locations | 28 sites (New Brunswick, New Jersey and 27 other locations) |
| Trial ID | NCT06590467 on ClinicalTrials.gov |
What this trial studies
The Abbott Structural Heart Registry aims to confirm the safety and performance of Abbott's structural heart devices in real-world clinical settings. It involves collecting data from routine hospital practices and standard-of-care procedures for patients undergoing implant attempts with these devices. Eligible patients will be enrolled either prospectively or retrospectively, with follow-up data collected at various intervals post-procedure. The registry will span approximately 5 years and include around 500 subjects per year across multiple sites worldwide.
Who should consider this trial
Good fit: Ideal candidates include patients scheduled for an implant attempt using Abbott Structural Heart devices or those who have recently undergone such a procedure.
Not a fit: Patients currently participating in other clinical studies that may influence the results of this registry may not benefit from participation.
Why it matters
Potential benefit: If successful, this registry could enhance the understanding of Abbott's heart devices' safety and effectiveness, leading to improved patient outcomes.
How similar studies have performed: Other observational registries for medical devices have shown success in confirming safety and performance, making this approach well-established.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Subject is expected to undergo an implant attempt using one or more Abbott Structural Heart devices covered in this Registry or has previously undergone an implant attempt within the timeframes specified in the device-specific appendices. 2. Subject is willing and able to comply with the site's standard of care follow-up schedule. 3. Subject is willing to provide appropriate informed consent for Registry participation. For deceased subjects enrolled retrospectively, local regulations and EC/IRB recommendations regarding consent and the protection of personal data must be followed. Exclusion Criteria: 1\. Subject is participating in another clinical study that would affect the results of this Registry.
Where this trial is running
New Brunswick, New Jersey and 27 other locations
- Robert Wood Johnson University Hospital — New Brunswick, New Jersey, United States (Not_yet_recruiting)
- Mount Sinai Hospital — New York, New York, United States (Not_yet_recruiting)
- University of Pennsylvania — Philadelphia, Pennsylvania, United States (Not_yet_recruiting)
- Upmc — Pittsburgh, Pennsylvania, United States (Not_yet_recruiting)
- Sentara Norfolk General Hospital — Norfolk, Virginia, United States (Not_yet_recruiting)
- Odense University Hospital — Odense, Southern Denmark, Denmark (Recruiting)
- Tartu University Hospital — Tartu, Tartu, Estonia (Recruiting)
- CHRU Hopital de Pontchaillou — Rennes, Brittan, France (Recruiting)
- Centre Médico Chirurgical Marie Lannelongue — Le Plessis-Robinson, France (Recruiting)
- Hopital Haut Leveque — Pessac, France (Recruiting)
- Deutsches Herzzentrum München des Freistaates Bayern — München, Bavaria, Germany (Recruiting)
- Klinikum Links der Weser — Bremen, Free Hanseatic City of Bremen, Germany (Recruiting)
- Universitatsklinikum Jena — Jena, Germany, Germany (Recruiting)
- Städt. Klinikum Braunschweig gGmbH — Braunschweig, L Saxon, Germany (Recruiting)
- Deutsches Herzzentrum der Charité — Berlin, State of Berlin, Germany (Recruiting)
- Schüchtermann-Schiller´sche Kliniken GmbH & Co. KG — Bad Rothenfelde, Germany (Recruiting)
- Children's Health Ireland (CHI) — Crumlin, Dublin, Ireland (Recruiting)
- IRCCS Policlinico San Donato - Cardio — San Donato Milanese, Lombardy, Italy (Recruiting)
- Policlinico San Donato — San Donato Milanese, Lombardy, Italy (Recruiting)
- A.O.U. Citta della Salute e della Scienza di Torino — Turin, Piedmont, Italy (Recruiting)
- Azienda Ospedaliero Universitaria Pisana — Pisa, Tuscany, Italy (Recruiting)
- Slaskie Centrum Chorob Serca — Zabrze, Silesian Voivodeship, Poland (Recruiting)
- Hospital Infantil Sant Joan De Deu — Esplugues de Llobregat, Catalonia, Spain (Recruiting)
- Hospital Universitario Central de Asturias — Oviedo, Principality of Asturias, Spain (Recruiting)
- Hospital Virgen de Rocio — Seville, Spain, Spain (Recruiting)
- Hospital Universitario de la Paz - Pediatrico — Madrid, Spain (Recruiting)
- Royal Brompton Hospital — London, UK, United Kingdom (Recruiting)
- St. Thomas Hospital — London, United Kingdom (Recruiting)
Study contacts
- Study coordinator: Laetitia Beullens
- Email: laetitia.beullens@abbott.com
- Phone: +32 277 46 937
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.